FOXP3 and systemic lupus erythematosus: Baicalin could become a promising therapeutic medicine for the treatment of SLE because Baicalin stimulated expansion of Foxp3+ regulatory T cells and ex vivo expanded Foxp3+ regulatory T cells could be used to treat lupus.